Association between dexamethasone treatment and the host response in COVID-19 patients admitted to the general ward

Dexamethasone improves clinical outcomes in COVID-19 patients requiring supplementary oxygen. We investigated possible mechanisms of action by comparing sixteen plasma host response biomarkers in general ward patients before and after implementation of dexamethasone as standard of care. 48 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: de Brabander, Justin, Michels, Erik H. A., van Linge, Christine C. A., Chouchane, Osoul, Douma, Renée A., Reijnders, Tom D. Y., Schuurman, Alex R., van Engelen, Tjitske S. R., Wiersinga, W. Joost, van der Poll, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163524/
https://www.ncbi.nlm.nih.gov/pubmed/35659223
http://dx.doi.org/10.1186/s12931-022-02060-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163524/
https://www.ncbi.nlm.nih.gov/pubmed/35659223
http://dx.doi.org/10.1186/s12931-022-02060-3

Ejemplares similares